5-MeO-PiPT, also known as 5-methoxy-N-propyl-N-isopropyltryptamine or by its nickname Poxy, is a substituted tryptamine derivative which is claimed to have psychedelic effects. It has been sold as a designer drug, first being identified in 2021 in British Columbia, Canada.
Use and effects 5-MeO-PiPT was not included nor mentioned in Alexander Shulgin's book TiHKAL (Tryptamines I Have Known and Loved).
Interactions
Pharmacology Pharmacodynamics 5-MeO-PiPT acts as a serotonin 5-HT1A and 5-HT2A receptor agonist, with an of 13.8nM and an efficacy of 89%.Patentscope. Banister S, Jorgensen W, Jinlong T. Compounds. Patent WO 2023/115167. Retrieved 2025-05-12
Chemistry Analogues Analogues of 5-MeO-PiPT include propylisopropyltryptamine (PiPT), 4-HO-PiPT, 5-MeO-DMT, 5-MeO-DPT, 5-MeO-DiPT, 5-MeO-MiPT, 5-MeO-EiPT, and 5-MeO-iPALT (ASR-3001), among others.
See also Substituted tryptamine
References
External links 5-MeO-PiPT - Isomer Design 5-MeO-PiPT Reports - Erowid Experience Vaults - Erowid